Sign in or create an account to add this stock to your watchlist.
About DiaSorin (OTCMKTS:DSRLF)
DiaSorin S.p.A. engages in the development, production, and commercialization of diagnostic tests that are designed for hospital and private testing laboratories for use in various clinical areas in the market of immunodiagnostics and molecular diagnostics. The company offers immunodiagnostics products in the areas of infectious diseases; bone and mineral metabolism; endocrinology, including diabetes, thyroid function, fertility, growth, adrenal function, and gastroenterology; hypertension; oncology; stool diagnostics; autoimmunity; and cardiac and brain damages. Its immunodiagnostics systems include LIAISON XL, an automated chemiluminescence analyzer; LIAISON analyzer; EVOlyzer 2-150/8 with disposable tips; and ETI Max 3000, an automated microtiter plate analyzer. The company also offers molecular diagnostic products for oncology, hematology, and infectious diseases; systems, including BULLET Pro and LIAISON Ixt to extract the nucleic acid from various biological samples; and LIAISON Iam to diagnose and various infectious diseases and onco-hematology parameters. It sells its products directly, as well as through an international network of independent distributors in Europe, Africa, Central America, South America, the Asia Pacific, and North America. DiaSorin S.p.A. was founded in 1968 and is headquartered in Saluggia, Italy.
Industry, Sector and Symbol
Industry Private households
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:DSRLF
CUSIPN/A
Phone390-161-4871
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E Ratio25.71
P/E Growth2.86
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding Shares55,950,000
DiaSorin (OTCMKTS:DSRLF) Frequently Asked Questions
What is DiaSorin's stock symbol?
DiaSorin trades on the OTCMKTS under the ticker symbol "DSRLF."
Who are some of DiaSorin's key competitors?
Some companies that are related to DiaSorin include Sunny Optical Technology (Group) (SNPTF), Sino Biopharm (SBMFF), SGS (SGSOY), Sysmex (SSMXY), OMV (OMVJF), Kerry Group (KRYAY), Kuehne + Nagel (KHNGY), MTN Group (MTNOY), AGRICULTURAL Bk/ADR (ACGBY), Deutsche Wohnen (DWHHF), Secom (SOMLY), thyssenkrupp (TKAMY), Aisin Seiki (ASEKY), thyssenkrupp (TYEKF) and Ashtead Group (ASHTY).
Who are DiaSorin's key executives?
DiaSorin's management team includes the folowing people:
- Mr. Carlo Rosa, CEO, GM & Exec. Director (Age 52)
- Dr. Chen Menachem Even, Chief Commercial Officer & Exec. Director (Age 55)
- Mr. Piergiorgio Pedron, Corp. Accounting Documents Officer, CFO & Sr. Corp. VP (Age 47)
- Mr. Riccardo Fava, Sr. Director of Investor Relations & Corp. Communication
- Mr. Marco Minolfo, Mang. of the Corp. Legal Affairs Department
Has DiaSorin been receiving favorable news coverage?
News articles about DSRLF stock have trended somewhat positive on Sunday, Accern reports. The research firm identifies positive and negative media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. DiaSorin earned a media sentiment score of 0.18 on Accern's scale. They also gave news headlines about the company an impact score of 44.79 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.
How do I buy shares of DiaSorin?
Shares of DSRLF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is DiaSorin's stock price today?
One share of DSRLF stock can currently be purchased for approximately $93.0562.
How big of a company is DiaSorin?
DiaSorin has a market capitalization of $5.21 billion.
How can I contact DiaSorin?
DiaSorin's mailing address is Via Crescentino, Saluggia L6, 13040. The company can be reached via phone at 390-161-4871 or via email at [email protected]
MarketBeat Community Rating for DiaSorin (DSRLF)
MarketBeat's community ratings are surveys of what our community members think about DiaSorin and other stocks. Vote "Outperform" if you believe DSRLF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DSRLF will underperform the S&P 500 over the long term. You may vote once every thirty days.
DiaSorin (OTCMKTS:DSRLF) Analyst Ratings History
| Date | Brokerage | Action | Rating | Price Target | Details |
|---|
(Data available from 5/20/2016 forward)
DiaSorin (OTCMKTS:DSRLF) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
DiaSorin (OTCMKTS DSRLF) Insider Trading and Institutional Ownership History
DiaSorin (OTCMKTS DSRLF) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
(Data available from 1/1/2013 forward)
DiaSorin (OTCMKTS DSRLF) News Headlines
| Source: |
|
DiaSorin (OTCMKTS:DSRLF) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
DiaSorin (OTCMKTS DSRLF) Stock Chart for Sunday, May, 20, 2018
Loading chart…
